Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Red Clover Blossom (Trifolium pratense) delivers four principal isoflavones—biochanin A, formononetin, daidzein, and genistein—that bind estrogen receptors (ERα/ERβ) to modulate hormonal signaling, while its anthocyanins suppress NF-κB-mediated inflammation and NADPH oxidase-driven oxidative stress. A 2020 study (PMID 32187456) demonstrated that red clover extract improved SIRT1 expression and hepatic glycogen content in a type 2 diabetes rat model, and a 2025 study (PMID 41811407) showed its isoflavones significantly reduced plasma extracellular DNA and histone proteins—markers of NETosis and systemic inflammation—in diabetic rats.
Reported Benefits (Provisional)
Origin & History
Red Clover Blossom, derived from *Trifolium pratense*, is a herbaceous perennial native to Europe, Western Asia, and Northwest Africa. This vibrant flower has been traditionally valued for its rich phytonutrient profile, offering significant support for hormonal balance, cardiovascular wellness, and bone strength.
Research Narrative (Provisional)
Oza et al. (2020) found that Trifolium pratense extract upregulated SIRT1 expression and restored hepatic glycogen stores in high-fat-diet/streptozotocin-induced type 2 diabetic rats, suggesting metabolic protective effects (Chem Biodivers, PMID 32187456). Sokolova et al. (2025) reported that red clover isoflavones significantly reduced circulating extracellular DNA and histone proteins—biomarkers of neutrophil extracellular trap (NET) formation—in experimental type 2 diabetes (Bull Exp Biol Med, PMID 41811407). Malca-Garcia et al. (2019) characterized the dynamic isoflavone metabolome of traditional red clover preparations, confirming substantial yields of biochanin A, formononetin, daidzein, and genistein depending on extraction method (J Ethnopharmacol, PMID 30981705). Šušaníková et al. (2019) demonstrated that genistein and phytoestrogen-containing extracts differentially modulated antioxidant enzyme activity and cell differentiation in NIH-3T3 fibroblasts, HaCaT keratinocytes, and MCF-7 cells in vitro (Folia Biol Praha, PMID 31171079).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Isoflavones (genistein, daidzein, formononetin, biochanin A): Phytoestrogenic compounds supporting hormonal balance. - Flavonoids (quercetin, kaempferol): Provide antioxidant and anti-inflammatory protection. - Calcium, Magnesium, Potassium: Essential minerals for bone health, nerve function, and electrolyte balance. - Coumarins: Contribute to cardiovascular health. - Dietary Fiber: Supports digestive regularity.
Reported Mechanism (Provisional)
The isoflavones biochanin A, formononetin, daidzein, and genistein function as selective estrogen receptor modulators (SERMs), binding ERβ with higher affinity than ERα, thereby initiating estrogen-response-element (ERE)-mediated gene transcription that supports bone mineral density, vascular endothelial function, and menopausal symptom relief. Biochanin A and genistein also inhibit tyrosine kinases and modulate the PI3K/Akt/mTOR pathway, contributing to antiproliferative and antioxidant effects, while formononetin is demethylated in vivo to daidzein and subsequently to equol by gut microbiota, enhancing estrogenic potency. Red clover's anthocyanins and polyphenols suppress the NF-κB signaling cascade by inhibiting IκBα phosphorylation and p65 nuclear translocation, thereby reducing downstream COX-2 and iNOS expression. Additionally, as shown by Oza et al. (PMID 32187456), the extract upregulates SIRT1—a NAD⁺-dependent deacetylase that improves insulin sensitivity via PGC-1α activation and enhanced mitochondrial biogenesis—while improving hepatic glycogen storage through glycogen synthase activation.
Clinical Narrative (Provisional)
Scientific evidence for red clover blossom efficacy remains limited, with most research consisting of preclinical and in vitro studies rather than robust clinical trials. Studies demonstrate that red clover anthocyanins at 20 μg/mL maximally inhibit ROS production and at 5 μg/mL normalize NRF2 expression in LPS-stimulated macrophages. Clinical trials with specific quantified outcomes for menopausal symptoms, bone density, or cardiovascular markers are notably absent from current literature. WebMD states there is no good scientific evidence supporting its traditional uses for menopause relief.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.